BioSpace News Archive

Deals

Germany’s BioNTech Taps Banks to Prepare for $800 Million IPO

For BioNTech, the IPO will follow a funding round that brought about $270 million into the coffers of the privately-held company.

March 13, 2019
·
2 min read
·
Alex Keown
Drug Development

Celgene’s Abraxane Fails to Hit the Mark in a Phase III Pancreatic Cancer Study

While the primary endpoint of disease-free survival was not met, Celgene said overall survival, which was a secondary endpoint, was improved by the combination treatment.

March 13, 2019
·
2 min read
·
Alex Keown
BioMidwest

AbbVie’s Humira Remains the Top-Selling Prescription for 2018

Humira generated nearly $20 billion in revenue for the Illinois-based company. Celgene’s Revlimid earned about half-as-much in 2018.

March 13, 2019
·
3 min read
·
Alex Keown
BioCapital

BioSpace’s Global Biopharma Roundup: March 14

In addition to the planned BioNTech IPO, many other pharma and biotech companies in Europe, Asia and elsewhere shared news for the week.

March 13, 2019
·
4 min read
·
Alex Keown
Biotech Beach

Commissioner Lara holds public hearing to highlight most expensive drugs and rising health costs

Insurance Commissioner Ricardo Lara will hold a public hearing on rising prescription drug and health care costs—including the top 25 drugs for which Californians and their health insurers spent the most money.

March 13, 2019
·
1 min read
Job Trends

ZEB1 throttles therapeutic target, protecting KRAS-mutant lung cancer

Protein forces a shift in cell type, a plasticity that promotes resistance to targeted therapy

March 13, 2019
·
5 min read
Deals

Koligo Therapeutics to bring 3D bio-printing to the ASX

Koligo Therapeutics a regenerative medicine and 3D bio-printing company to list on the ASX under the stock ticker “KOL”.

March 13, 2019
·
5 min read
Tomocube 3D Microscope captures Key Cellular Dynamic Responses to Parkinson Drug Treatment

Although Parkinson’s disease (PD) is a relatively common neurodegenerative disease, therapeutic treatments are still limited due to its complex pathophysiology.

March 13, 2019
·
3 min read
Job Trends

DJO® Launches First Fully Sterile, Surgeon-Controlled Leg and Retractor Holder for Anterior Approach Hip Arthroplasty at AAOS

Intuitive, versatile, lightweight surgical arm makes benefits of Direct Anterior Approach available to more surgeons and their patients

March 13, 2019
·
4 min read
Business

Seven are Honored for Championing Global Health Work with Golisano Global Health Leadership Awards

The Golisano Foundation and Special Olympics honored seven healthcare organizations and professionals who are on the frontlines of bringing essential and often unprecedented health care services to the most marginalized people on earth, those with intellectual disabilities (ID)

March 13, 2019
·
6 min read